CRL
Price
$161.29
Change
-$2.02 (-1.24%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
8.04B
57 days until earnings call
ICLR
Price
$177.98
Change
+$0.04 (+0.02%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
13.84B
50 days until earnings call
Interact to see
Advertisement

CRL vs ICLR

Header iconCRL vs ICLR Comparison
Open Charts CRL vs ICLRBanner chart's image
Charles River Laboratories International
Price$161.29
Change-$2.02 (-1.24%)
Volume$3.78K
Capitalization8.04B
ICON
Price$177.98
Change+$0.04 (+0.02%)
Volume$13.16K
Capitalization13.84B
CRL vs ICLR Comparison Chart in %
Loading...
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRL vs. ICLR commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a Hold and ICLR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (CRL: $163.31 vs. ICLR: $177.94)
Brand notoriety: CRL and ICLR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CRL: 99% vs. ICLR: 43%
Market capitalization -- CRL: $8.04B vs. ICLR: $13.84B
CRL [@Medical Specialties] is valued at $8.04B. ICLR’s [@Medical Specialties] market capitalization is $13.84B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $10.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRL’s FA Score shows that 1 FA rating(s) are green whileICLR’s FA Score has 0 green FA rating(s).

  • CRL’s FA Score: 1 green, 4 red.
  • ICLR’s FA Score: 0 green, 5 red.
According to our system of comparison, CRL is a better buy in the long-term than ICLR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRL’s TA Score shows that 6 TA indicator(s) are bullish while ICLR’s TA Score has 2 bullish TA indicator(s).

  • CRL’s TA Score: 6 bullish, 3 bearish.
  • ICLR’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, CRL is a better buy in the short-term than ICLR.

Price Growth

CRL (@Medical Specialties) experienced а +0.91% price change this week, while ICLR (@Medical Specialties) price change was +1.20% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.10%. For the same industry, the average monthly price growth was +9.54%, and the average quarterly price growth was +9.36%.

Reported Earning Dates

CRL is expected to report earnings on Oct 29, 2025.

ICLR is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Medical Specialties (+0.10% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ICLR($13.8B) has a higher market cap than CRL($8.04B). CRL has higher P/E ratio than ICLR: CRL (577.05) vs ICLR (18.33). CRL YTD gains are higher at: -11.533 vs. ICLR (-15.149). ICLR has higher annual earnings (EBITDA): 1.37B vs. CRL (528M). ICLR has more cash in the bank: 390M vs. CRL (183M). CRL has less debt than ICLR: CRL (2.79B) vs ICLR (3.55B). ICLR has higher revenues than CRL: ICLR (8.09B) vs CRL (4.03B).
CRLICLRCRL / ICLR
Capitalization8.04B13.8B58%
EBITDA528M1.37B38%
Gain YTD-11.533-15.14976%
P/E Ratio577.0518.333,149%
Revenue4.03B8.09B50%
Total Cash183M390M47%
Total Debt2.79B3.55B79%
FUNDAMENTALS RATINGS
CRL vs ICLR: Fundamental Ratings
CRL
ICLR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
68
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9277
PRICE GROWTH RATING
1..100
5856
P/E GROWTH RATING
1..100
194
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ICLR's Valuation (68) in the Pharmaceuticals Other industry is in the same range as CRL (92) in the Miscellaneous Commercial Services industry. This means that ICLR’s stock grew similarly to CRL’s over the last 12 months.

ICLR's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as CRL (100) in the Miscellaneous Commercial Services industry. This means that ICLR’s stock grew similarly to CRL’s over the last 12 months.

ICLR's SMR Rating (77) in the Pharmaceuticals Other industry is in the same range as CRL (92) in the Miscellaneous Commercial Services industry. This means that ICLR’s stock grew similarly to CRL’s over the last 12 months.

ICLR's Price Growth Rating (56) in the Pharmaceuticals Other industry is in the same range as CRL (58) in the Miscellaneous Commercial Services industry. This means that ICLR’s stock grew similarly to CRL’s over the last 12 months.

CRL's P/E Growth Rating (1) in the Miscellaneous Commercial Services industry is significantly better than the same rating for ICLR (94) in the Pharmaceuticals Other industry. This means that CRL’s stock grew significantly faster than ICLR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLICLR
RSI
ODDS (%)
Bearish Trend 5 days ago
64%
Bearish Trend 6 days ago
57%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
67%
Bearish Trend 5 days ago
67%
Momentum
ODDS (%)
Bullish Trend 5 days ago
67%
Bullish Trend 5 days ago
64%
MACD
ODDS (%)
Bullish Trend 5 days ago
84%
Bearish Trend 5 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
69%
Bullish Trend 5 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
73%
Bearish Trend 5 days ago
69%
Advances
ODDS (%)
Bullish Trend 5 days ago
69%
Bullish Trend 5 days ago
68%
Declines
ODDS (%)
Bearish Trend 7 days ago
69%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 5 days ago
69%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NORW29.750.14
+0.47%
Global X MSCI Norway ETF
MLPB26.110.07
+0.28%
UBS ETRACS Alerian MLPInfrs ETN SerB
FMAY51.43-0.12
-0.23%
FT Vest US Equity Buffer ETF May
KAUG25.59-0.08
-0.32%
Innovator U.S. Small Cp Pwr Buf ETF -Aug
RXD11.74-0.14
-1.19%
ProShares UltraShort Health Care

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been loosely correlated with RVTY. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CRL jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
+0.06%
RVTY - CRL
61%
Loosely correlated
+0.99%
NOTV - CRL
58%
Loosely correlated
+0.60%
ICLR - CRL
58%
Loosely correlated
+1.65%
A - CRL
58%
Loosely correlated
+0.56%
AZTA - CRL
56%
Loosely correlated
+2.07%
More

ICLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICLR has been loosely correlated with TMO. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ICLR jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICLR
1D Price
Change %
ICLR100%
+1.65%
TMO - ICLR
61%
Loosely correlated
+0.61%
MEDP - ICLR
56%
Loosely correlated
+0.54%
CRL - ICLR
55%
Loosely correlated
+0.06%
BRKR - ICLR
54%
Loosely correlated
+1.55%
RVTY - ICLR
52%
Loosely correlated
+0.99%
More